Worktype S2 - SYNERGISM REPORTED FOR

Worktype Details

CodeS2
NameSYNERGISM REPORTED FOR

Experiments (59 results)

Filters
Worktypes (16)
59
20
18
15
12
10
6
6
4
4
3
3
2
2
1
1
No match
Pharmacology (30)
9
4
4
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Compounds (31)
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
22
No match
Organisms (48)
4
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
59 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
50782
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTITUSSIVE ACTIVITY
Empty organism
EPHEDRINE
342056
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIBACTERIAL ACTIVITY
Empty organism
CORDOIN,4-HYDROXY:
338664
SYNERGISM REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANS
CNS STIMULANT ACTIVITY
Empty organism
EPHEDRINE
409645
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOBOOK MARKER CODETOXICITY MARKER CODEMECHANISM OF ACTION STUDIEDREVIEW OF
HYPOGLYCEMIC ACTIVITY
Empty organism
HYPOGLYCIN A
1120170
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTITRICHOMONAL ACTIVITY
Prenanthes purpurea (ASTERACEAE)
994354
SYNERGISM REPORTED FOR
Empty organism
PROSTAGLANDIN F-2-ALPHAPROSTAGLANDIN E-2
1313249
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGS
ANTIBACTERIAL ACTIVITY
Panax ginseng (ARALIACEAE)
1303770
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGS
ANTIYEAST ACTIVITY
Echinophora platyloba (APIACEAE)
61958
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIBACTERIAL ACTIVITY
Hamamelis virginiana (HAMAMELIDACEAE)
1303590
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
ANTIYEAST ACTIVITY
Empty organism
BAICALEIN
1303858
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
APOPTOSIS INDUCTION
Empty organism
BERBERINE
1028841
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
SPORE GERMINATION INHIBITOR
Monocillium nordinii (HYPHOMYCETES)
MONORDEN
1303673
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FORREVIEW OF
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Nigella sativa (RANUNCULACEAE)
1303671
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FORREVIEW OF
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Adhatoda vasica (ACANTHACEAE)
61728
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIMYCOBACTERIAL ACTIVITY
Smilax ornata (LILIACEAE)
1145610
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
EMBRYOTOXIC EFFECT(RELATED TO GENERAL TOXIC EFFECTS)
Empty organism
CAFFEINE
821367
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
ETOPOSIDE*
51442
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOR
BARBITURATE POTENTIATION
Valeriana jatamansi (VALERIANACEAE)
592720
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIVIRAL ACTIVITY
Cynodon dactylon (POACEAE)
13574
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Gaultheria procumbens (ERICACEAE)
SALICYLIC ACID METHYL ESTER
51446
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOR
BARBITURATE POTENTIATION
Lallemantia royleana (LAMIACEAE)
338663
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
CNS STIMULANT ACTIVITY
Empty organism
EPHEDRINE
520081
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIBACTERIAL ACTIVITY
Curcuma longa (ZINGIBERACEAE)
320963
SYNERGISM REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
LIVER EFFECTS(UNSPECIFIED)
Empty organism
CYNARINSILYBIN
1268869
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOR
BARBITURATE POTENTIATION
Withania ashvagandha (SOLANACEAE)
338667
SYNERGISM REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANS
CNS STIMULANT ACTIVITY
Empty organism
STRYCHNINE
1057222
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
LIPOLYTIC EFFECT
Empty organism
FORSKOLIN
1180371
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CADEGUOMYCIN
196122
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Streptomyces flaveus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SW-B
1145612
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SISTER CHROMATID EXCHANGE STIMULATION
Empty organism
BENZO-(A)-PYRENE
1116562
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIBACTERIAL ACTIVITY
Kickxia incana (SCROPHULARIACEAE)
332992
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIULCER ACTIVITY
Empty organism
AZULENE
50784
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTITUSSIVE ACTIVITY
Empty organism
CODEINE
332958
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE
CARCINOGENIC ACTIVITY
Empty organism
OCHRATOXIN A
50698
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOR
BARBITURATE POTENTIATION
Kochia prostrata (CHENOPODIACEAE)
50836
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
DIURETIC ACTIVITY
Saponaria officinalis (CARYOPHYLLACEAE)
VITEXOSIDE
338666
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
CNS STIMULANT ACTIVITY
Empty organism
STRYCHNINE
50683
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
SMOOTH MUSCLE STIMULANT ACTIVITY
Bupleurum falcatum (APIACEAE)
62471
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIBACTERIAL ACTIVITY
Conyza canadensis (ASTERACEAE)
1268866
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOR
CNS DEPRESSANT ACTIVITY
Withania ashvagandha (SOLANACEAE)
338613
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPHEROMONE MARKER CODE
PHEROMONE(INSECT SEX ATTRACTANT)
Empty organism
TETRADECA-CIS-9-TRANS-12-DIEN-1-OL ACETATETETRADECA-CIS-9-TRANS-11-DIEN-1-OL ACETATE
196121
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Streptomyces flaveus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SW-B
412227
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIBACTERIAL ACTIVITY
Empty organism
THALIGLUCINONE
1180370
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CADEGUOMYCIN
332960
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE
CARCINOGENIC ACTIVITY
Empty organism
PENICILLIC ACID
175162
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Streptomyces albulus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC IC-101
1170201
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGS
HYPOLIPEMIC ACTIVITY
Commiphora mukul (BURSERACEAE)
1145609
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SISTER CHROMATID EXCHANGE STIMULATION
Empty organism
CAFFEINE
332959
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
OCHRATOXIN A
1220726
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIFUNGAL ACTIVITY
Equisetum arvense (EQUISETACEAE)
1057218
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
HARRINGTONINE,EPI:
342171
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSTOXICITY MARKER CODEMECHANISM OF ACTION STUDIEDREVIEW OF
HYPOGLYCEMIC ACTIVITY
Empty organism
HYPOGLYCIN A
410003
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Empty organism
ORIODONIN
955316
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
MOLLUSCICIDAL ACTIVITY
Ambrosia maritima (ASTERACEAE)
62156
PHARMACOLOGY OF EXTRACT - IN VITROSYNERGISM REPORTED FOR
ANTIBACTERIAL ACTIVITY
Eryngium amethystinum (APIACEAE)
963205
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Narcissus pseudo-narcissus (AMARYLLIDACEAE)
NARCISSUS MANNOSE-SPECIFIC LECTIN
1268867
PHARMACOLOGY OF EXTRACT - IN VIVOSYNERGISM REPORTED FOR
CNS DEPRESSANT ACTIVITY
Withania ashvagandha (SOLANACEAE)
332961
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
PENICILLIC ACID
1145615
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
EMBRYOTOXIC EFFECT(RELATED TO GENERAL TOXIC EFFECTS)
Empty organism
BENZO-(A)-PYRENE
Show SPARQL Queries (1)